NewAmsterdam Pharma Company N.V. (NAMS)
USD 20.03
(0.0%)
USD 20.03
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -309.31 Million EUR | 29.45% |
| 2022 | -438.4 Million EUR | -728.3% |
| 2021 | -52.92 Million EUR | -1496.89% |
| 2020 | 3.78 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -400.81 Million EUR | 3.39% |
| 2024 Q1 | -414.89 Million EUR | -34.13% |
| 2023 Q2 | -383.4 Million EUR | 0.0% |
| 2023 FY | -309.31 Million EUR | 29.45% |
| 2023 Q1 | - EUR | 100.0% |
| 2023 Q4 | -309.31 Million EUR | 0.0% |
| 2023 Q3 | - EUR | 100.0% |
| 2022 Q1 | -712.16 Thousand EUR | 98.65% |
| 2022 FY | -438.4 Million EUR | -728.3% |
| 2022 Q4 | -438.4 Million EUR | -114306.95% |
| 2022 Q3 | -383.19 Thousand EUR | 99.57% |
| 2022 Q2 | -89.32 Million EUR | -12443.11% |
| 2021 Q1 | -948.22 Thousand EUR | -152.77% |
| 2021 FY | -52.92 Million EUR | -1496.89% |
| 2021 Q4 | -52.92 Million EUR | -9579.41% |
| 2021 Q3 | -546.81 Thousand EUR | 17.75% |
| 2021 Q2 | -664.82 Thousand EUR | 29.89% |
| 2020 Q4 | 1.79 Million EUR | 89.69% |
| 2020 FY | 3.78 Million EUR | 0.0% |
| 2020 Q2 | 947.25 Thousand EUR | 0.0% |
| 2020 Q1 | 947.25 Thousand EUR | 0.0% |
| 2020 Q3 | 947.25 Thousand EUR | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -12087.23% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 4586.294% |
| XOMA Corporation | -29 Million USD | -966.593% |
| Mesoblast Limited | 55.96 Million USD | 652.708% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 291.238% |
| Aptorum Group Limited | 1.35 Million USD | 22893.03% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 34567.063% |
| HilleVax, Inc. | -165.48 Million USD | -86.912% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -902.242% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 4538.986% |
| Precision BioSciences, Inc. | -85.41 Million USD | -262.15% |
| Dyadic International, Inc. | -6.37 Million USD | -4749.594% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3583.162% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -100.662% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1841.329% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -915.469% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -12.153% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 288.183% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -830.066% |
| IGM Biosciences, Inc. | -72.6 Million USD | -326.014% |
| Opthea Limited | 28.15 Million USD | 1198.508% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 913.658% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -3309.147% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1943.686% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1742.349% |
| NextCure, Inc. | -6.47 Million USD | -4675.543% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -3520.573% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1731.374% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 7542.539% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 2.36% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -299.365% |
| Senti Biosciences, Inc. | 1.74 Million USD | 17876.546% |
| Apollomics, Inc. | -27.39 Million USD | -1029.082% |
| PureTech Health plc | -167.19 Million USD | -84.998% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4748.909% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -139.565% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -1122.963% |
| ChromaDex Corporation | -24.04 Million USD | -1186.227% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -4156.93% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 604.941% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -4256.506% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -4058.461% |
| Gritstone bio, Inc. | 39.49 Million USD | 883.266% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -3283.597% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 601.592% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 955.327% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4135.38% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -6176.621% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -249.663% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -275.014% |
| Celcuity Inc. | 6.78 Million USD | 4659.763% |
| ContextLogic Inc. | -232 Million USD | -33.324% |
| GH Research PLC | -78.07 Million USD | -296.163% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -179.827% |
| Cassava Sciences, Inc. | -121.13 Million USD | -155.343% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -9158.064% |
| ImmuCell Corporation | 10.99 Million USD | 2914.341% |
| Amarin Corporation plc | -191.04 Million USD | -61.909% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1831.676% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -651.03% |
| Acelyrin, Inc. | -216.9 Million USD | -42.604% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -35779.347% |
| Seer, Inc. | -4.24 Million USD | -7195.092% |
| Novavax, Inc. | -298.29 Million USD | -3.694% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -27.623% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 106.738% |
| AnaptysBio, Inc. | -18.15 Million USD | -1604.104% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2588.033% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -1125.386% |
| AbCellera Biologics Inc. | -55.94 Million USD | -452.935% |
| CorMedix Inc. | -43.05 Million USD | -618.453% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -368.967% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1946.871% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -1041.372% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3674.464% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -9785.271% |
| Soligenix, Inc. | -4.95 Million USD | -6146.71% |
| Century Therapeutics, Inc. | 847 Thousand USD | 36618.525% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 7326.914% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -13249.517% |
| Kura Oncology, Inc. | -20.11 Million USD | -1437.488% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -662.378% |
| Ardelyx, Inc. | 34.51 Million USD | 996.245% |
| Ainos, Inc. | 4.07 Million USD | 7685.026% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -655.783% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 17079.347% |
| Prothena Corporation plc | -608.34 Million USD | 49.155% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -9575.067% |
| Autolus Therapeutics plc | -186.59 Million USD | -65.763% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -527.357% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -160.46% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 1002.626% |
| Celularity Inc. | 65.19 Million USD | 574.478% |
| Rallybio Corporation | -24.1 Million USD | -1183.345% |
| GRI Bio, Inc. | -1.79 Million USD | -17141.466% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -3343.285% |
| Omeros Corporation | 331.17 Million USD | 193.398% |
| INmune Bio, Inc. | -25.41 Million USD | -1117.236% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 304.909% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -510.576% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1803.531% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -10621.658% |
| Humacyte, Inc. | -22.48 Million USD | -1275.576% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 1070.086% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 181.839% |
| Immunocore Holdings plc | -358.59 Million USD | 13.743% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -1158.645% |
| Verastem, Inc. | -37.27 Million USD | -729.744% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -496.413% |
| Histogen Inc. | -7.48 Million USD | -4031.32% |
| Surrozen, Inc. | -32.66 Million USD | -846.95% |
| Blueprint Medicines Corporation | 702.83 Million USD | 144.009% |
| Organovo Holdings, Inc. | -1.5 Million USD | -20425.01% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -7258.458% |
| IO Biotech, Inc. | -140.69 Million USD | -119.839% |
| MEI Pharma, Inc. | -3.7 Million USD | -8248.5% |
| GT Biopharma, Inc. | -1.02 Million USD | -30194.996% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -612.011% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -2021.938% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -64.335% |
| Summit Therapeutics Inc. | 34.67 Million USD | 992.057% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -5002.473% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2928.313% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -42737.424% |
| Turnstone Biologics Corp. | -14.58 Million USD | -2020.899% |
| Pulmatrix, Inc. | -10.41 Million USD | -2869.299% |
| Synaptogenix, Inc. | -28.66 Million USD | -979.19% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -32946.144% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 734.72% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -710.948% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -177.654% |
| Cytokinetics, Incorporated | 642.37 Million USD | 148.152% |
| Exelixis, Inc. | -73.05 Million USD | -323.425% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -1188.102% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -28.148% |
| Evogene Ltd. | -19.63 Million USD | -1475.389% |
| Replimune Group, Inc. | 1.41 Million USD | 22005.942% |
| PDS Biotechnology Corporation | -32.7 Million USD | -845.651% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -3248.551% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -267.786% |
| ESSA Pharma Inc. | -33.62 Million USD | -819.98% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -11651.347% |
| BioLineRx Ltd. | 7.33 Million USD | 4316.356% |
| Avid Bioservices, Inc. | 169.72 Million USD | 282.24% |
| Insmed Incorporated | 721.62 Million USD | 142.864% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -164.265% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1844.076% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -312.009% |
| MediWound Ltd. | -5.32 Million USD | -5711.949% |
| MiMedx Group, Inc. | -33.9 Million USD | -812.398% |
| OmniAb, Inc. | 9.2 Million USD | 3460.99% |
| Alector, Inc. | -35.63 Million USD | -767.952% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 459.786% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -72.824% |
| Mereo BioPharma Group plc | -51.46 Million USD | -500.967% |
| Zai Lab Limited | -775 Million USD | 60.089% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 190.826% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -5.294% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1336.989% |
| Immunic, Inc. | -45.34 Million USD | -582.205% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -228.318% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -60.087% |
| Veracyte, Inc. | -203.82 Million USD | -51.754% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 148.459% |
| FibroGen, Inc. | 56.76 Million USD | 644.88% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3573.463% |
| Allakos Inc. | -24.97 Million USD | -1138.486% |
| scPharmaceuticals Inc. | -6.54 Million USD | -4625.927% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1998.168% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -128.443% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -10841.031% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 42122.306% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -14840.093% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -86.373% |
| Precigen, Inc. | -481 Thousand USD | -64206.01% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 119.709% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -1163.942% |
| Incyte Corporation | -3.17 Billion USD | 90.258% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -410487.393% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -3330.7% |
| XBiotech Inc. | -200.02 Million USD | -54.638% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -148.172% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -267.786% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1570.164% |
| CRISPR Therapeutics AG | -150.84 Million USD | -105.053% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -48.59% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -233.443% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 6931.093% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -777.157% |
| Agenus Inc. | 274.13 Million USD | 212.832% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -13074.582% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -300.57% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 5535.106% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -81.505% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -234.847% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -25933.397% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 142.011% |
| UroGen Pharma Ltd. | 4.39 Million USD | 7144.225% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2772.63% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 372.567% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -8858.622% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1287.796% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -3345.968% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -67.552% |
| Chimerix, Inc. | -25.51 Million USD | -1112.18% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -1060.253% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2643.0% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -15602.611% |
| Pluri Inc. | 22.82 Million USD | 1454.908% |
| Cue Biopharma, Inc. | -33.81 Million USD | -814.61% |
| MeiraGTx Holdings plc | -40.3 Million USD | -667.485% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1331.548% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3590.566% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -900.977% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1753.036% |
| CalciMedica, Inc. | -5.53 Million USD | -5493.344% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -672.565% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -830.177% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -5075.036% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 42122.306% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -416.001% |
| Nutriband Inc. | -251.65 Thousand USD | -122810.115% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -806.568% |
| Vor Biopharma Inc. | 4.3 Million USD | 7293.3% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 94.876% |
| ProKidney Corp. | -56.23 Million USD | -450.025% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -535.503% |
| Daré Bioscience, Inc. | -5.15 Million USD | -5896.845% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 122.678% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4882.473% |
| Bicycle Therapeutics plc | -481.46 Million USD | 35.756% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -1026.204% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 770.275% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 49.143% |
| Atai Life Sciences N.V. | -28.55 Million USD | -983.101% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 13967.2% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1255.68% |
| MediciNova, Inc. | -50.78 Million USD | -509.079% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -292.503% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1374925.148% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4693.609% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -66.668% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -54.794% |
| Biomea Fusion, Inc. | -166.57 Million USD | -85.695% |
| RenovoRx, Inc. | -1.17 Million USD | -26269.302% |
| Erasca, Inc. | -37.21 Million USD | -731.126% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -226.127% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6874.242% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -31.938% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -223.223% |
| bluebird bio, Inc. | 108.57 Million USD | 384.894% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -691.626% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1678.063% |
| Imunon, Inc. | -4.21 Million USD | -7240.36% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 181.667% |
| BioAtla, Inc. | -109.01 Million USD | -183.744% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2684.923% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1358.812% |
| DBV Technologies S.A. | -126.98 Million USD | -143.58% |
| Fortress Biotech, Inc. | 7.66 Million USD | 4135.38% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -76.518% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1767.826% |
| aTyr Pharma, Inc. | -7.44 Million USD | -4052.395% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -278.229% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -35900.66% |
| Galecto, Inc. | -21.21 Million USD | -1357.918% |
| Akari Therapeutics, Plc | -3.84 Million USD | -7944.523% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 19159.327% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 122.4% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 469.995% |
| Entera Bio Ltd. | -10.62 Million USD | -2810.075% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 189.24% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -4446.699% |
| Xencor, Inc. | 29.64 Million USD | 1143.422% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -971.321% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -237.198% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -126197.184% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -144.676% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -25933.397% |
| Portage Biotech Inc. | -4.98 Million USD | -6109.836% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1374925.148% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -367.79% |
| OncoCyte Corporation | -6.56 Million USD | -4612.965% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -6689.643% |
| Purple Biotech Ltd. | -14.13 Million USD | -2087.805% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1202.037% |
| Onconetix, Inc. | 5.33 Million USD | 5901.661% |
| MacroGenics, Inc. | -66.98 Million USD | -361.763% |
| Tharimmune, Inc. | -10.93 Million USD | -2728.55% |
| Genprex, Inc. | -6.73 Million USD | -4490.812% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -166.002% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 16.132% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -512.487% |
| Prime Medicine, Inc. | -27.94 Million USD | -1007.018% |
| Aditxt, Inc. | 18.12 Million USD | 1806.936% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -21977.938% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -9225.202% |
| OKYO Pharma Limited | -826.84 Thousand USD | -37308.557% |
| Savara Inc. | 153 Thousand USD | 202264.645% |
| Curis, Inc. | -23.88 Million USD | -1194.896% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -39759.165% |
| Adagene Inc. | -87.62 Million USD | -252.985% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 26202.271% |
| BeiGene, Ltd. | -2.25 Billion USD | 86.272% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -356.327% |
| GlycoMimetics, Inc. | -40.98 Million USD | -654.706% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 959.08% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -23916.895% |
| SciSparc Ltd. | -2.06 Million USD | -14878.785% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -23916.895% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2887.943% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2479.383% |
| Minerva Neurosciences, Inc. | 41 Million USD | 854.341% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2746.079% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 365.292% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -885.98% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 116.541% |
| ADMA Biologics, Inc. | 90.06 Million USD | 443.428% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1212.913% |
| Clene Inc. | 3.34 Million USD | 9360.836% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -858.453% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -799.79% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1337.924% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 10.116% |
| Adicet Bio, Inc. | -138.78 Million USD | -122.868% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 274.097% |
| Absci Corporation | -72.59 Million USD | -326.061% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7325.693% |
| Quantum-Si incorporated | -118.55 Million USD | -160.897% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -4038.401% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -537.638% |
| Surrozen, Inc. | -32.66 Million USD | -846.95% |
| Generation Bio Co. | 31.44 Million USD | 1083.566% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -76.383% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1206.381% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -900.265% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5895.614% |
| Invivyd, Inc. | -198.47 Million USD | -55.843% |
| Cingulate Inc. | 3.08 Million USD | 10133.854% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -242.652% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -12800.422% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -3229.075% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -336.943% |
| Jaguar Health, Inc. | 29.39 Million USD | 1152.403% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -4432.043% |
| 2seventy bio, Inc. | 181.71 Million USD | 270.218% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 2296.662% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -289.94% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -135.304% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -3305.505% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -1089.676% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -7459.742% |
| Kronos Bio, Inc. | -36.05 Million USD | -757.913% |
| Innoviva, Inc. | 255.56 Million USD | 221.032% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 3387.405% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 49353.488% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -5838.029% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -137.377% |
| Evaxion Biotech A/S | 5.28 Million USD | 5950.596% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -174.778% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -135.625% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -500.489% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -10431.56% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 4403.769% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -193.07% |
| Clearmind Medicine Inc. | -3.94 Million USD | -7745.305% |
| AlloVir, Inc. | -62.69 Million USD | -393.383% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -2248.431% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -130.694% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 21312.961% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -470.097% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 2.334% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -17841.526% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -9660.552% |
| ImmunityBio, Inc. | 618.22 Million USD | 150.032% |
| Korro Bio, Inc. | -132.94 Million USD | -132.665% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -456.176% |
| Kineta, Inc. | -4.54 Million USD | -6711.537% |
| Lantern Pharma Inc. | -21.7 Million USD | -1325.185% |
| BioVie Inc. | -17.73 Million USD | -1644.337% |
| Codexis, Inc. | -43.27 Million USD | -614.825% |
| Celularity Inc. | 65.19 Million USD | 574.478% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -7214.067% |
| Virax Biolabs Group Limited | -3.36 Million USD | -9092.186% |
| Kodiak Sciences Inc. | -103.87 Million USD | -197.773% |
| Cibus, Inc. | -8.07 Million USD | -3729.065% |
| Annexon, Inc. | -193.75 Million USD | -59.641% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1667.598% |
| Moderna, Inc. | -2.9 Billion USD | 89.36% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 129.339% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 859299.742% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -8704.78% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1666.508% |
| Eyenovia, Inc. | 1.25 Million USD | 24673.879% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1249.645% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -276.925% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -83.859% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9437.832% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -830.345% |
| Alkermes plc | -166.73 Million USD | -85.507% |
| Arcellx, Inc. | -296.95 Million USD | -4.16% |
| Moolec Science SA | 117.61 Thousand USD | 263084.549% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1485.727% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -715.739% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -425.371% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1392.314% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -118.717% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1275.025% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -4325.428% |
| Humacyte, Inc. | -22.48 Million USD | -1275.576% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -705.521% |
| Geron Corporation | 14.76 Million USD | 2195.467% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -1186.816% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -17247.836% |
| Royalty Pharma plc | 5.65 Billion USD | 105.467% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -5667.668% |
| Notable Labs, Ltd. | -9.77 Million USD | -3063.993% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -119.789% |
| Structure Therapeutics Inc. | -124.33 Million USD | -148.765% |
| IN8bio, Inc. | -16.38 Million USD | -1787.314% |
| 89bio, Inc. | -289.05 Million USD | -7.009% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -7365.892% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3953.394% |
| Acasti Pharma Inc. | -23 Million USD | -1244.542% |
| Genelux Corporation | -6.89 Million USD | -4383.431% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -895.885% |
| Liquidia Corporation | -80.17 Million USD | -285.791% |
| Mustang Bio, Inc. | -3.73 Million USD | -8179.227% |
| Immunovant, Inc. | -635.22 Million USD | 51.307% |
| Vericel Corporation | 1.27 Million USD | 24321.762% |
| Quantum-Si incorporated | -118.55 Million USD | -160.897% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1661.056% |
| XOMA Corporation | -29 Million USD | -966.593% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -337.518% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -9085.948% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1803.531% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -12111.287% |
| Vaxcyte, Inc. | -368.22 Million USD | 16.0% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -124.562% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -7325.693% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1291.291% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1565.743% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -5178.36% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -425.853% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -82.724% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 291903.686% |
| PepGen Inc. | -60.67 Million USD | -409.827% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1246.239% |
| United Therapeutics Corporation | -507.7 Million USD | 39.076% |
| Solid Biosciences Inc. | -47.75 Million USD | -547.774% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -35779.347% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -9437.832% |
| Immuneering Corporation | -54.94 Million USD | -462.97% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -7258.458% |
| Silo Pharma, Inc. | -3.52 Million USD | -8676.529% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 310128.072% |
| Belite Bio, Inc | -87.27 Million USD | -254.427% |
| Pharming Group N.V. | 109.8 Million USD | 381.695% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1570.164% |
| Bionomics Limited | 227 Million USD | 236.255% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 3133.957% |
| uniQure N.V. | -102.95 Million USD | -200.446% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2572.32% |
| GeoVax Labs, Inc. | -6.45 Million USD | -4693.609% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 855.322% |
| Altimmune, Inc. | -134.48 Million USD | -129.994% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -9896.507% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -12111.287% |
| Peak Bio, Inc. | 10.34 Million USD | 3091.365% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3573.463% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -4070.873% |
| Benitec Biopharma Inc. | -50.58 Million USD | -511.506% |
| Zura Bio Limited | -99.8 Million USD | -209.913% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 256.167% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -5413.319% |
| Compugen Ltd. | -12.9 Million USD | -2297.023% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -9825.416% |
| argenx SE | -2.02 Billion USD | 84.754% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -109197.494% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1517.233% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -196.452% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1674.507% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1890.207% |
| PolyPid Ltd. | 6.17 Million USD | 5113.159% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 517.312% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -6973.22% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2486.004% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -134.79% |
| Instil Bio, Inc. | 75.35 Million USD | 510.457% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1517.909% |
| Immunome, Inc. | -97.02 Million USD | -218.783% |
| Verona Pharma plc | -220.44 Million USD | -40.314% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -13419.013% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -331.139% |
| Shattuck Labs, Inc. | -121.42 Million USD | -154.737% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -66.746% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1604.198% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -339.482% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2853.845% |
| Achilles Therapeutics plc | -126.92 Million USD | -143.699% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 190.921% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1403.189% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 30.876% |
| Beam Therapeutics Inc. | -262.72 Million USD | -17.734% |
| Moolec Science SA | 117.61 Thousand USD | 263084.549% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -2132.332% |
| AEON Biopharma, Inc. | -4.88 Million USD | -6238.359% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -453.687% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -209.746% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -692.579% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -271.403% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 2045.556% |
| Athira Pharma, Inc. | -88.99 Million USD | -247.545% |
| HCW Biologics Inc. | 2.85 Million USD | 10927.686% |
| XOMA Corporation | -29 Million USD | -966.593% |
| NeurAxis, Inc. | 145.7 Thousand USD | 212393.69% |
| Lumos Pharma, Inc. | -28.49 Million USD | -985.572% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -331.139% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -47070.62% |
| Nektar Therapeutics | 210.24 Million USD | 247.123% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1674.507% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1388.95% |
| Arvinas, Inc. | -313.8 Million USD | 1.43% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 21312.961% |
| Palisade Bio, Inc. | -12.06 Million USD | -2464.138% |
| Nutriband Inc. | -251.65 Thousand USD | -122810.115% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 19159.327% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -4057.418% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -120.447% |
| Merus N.V. | -192.88 Million USD | -60.362% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 615.649% |
| Neurogene Inc. | -131.95 Million USD | -134.407% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1517.821% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -6200.915% |
| CervoMed Inc. | -7.79 Million USD | -3869.178% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 17.996% |
| Sesen Bio, Inc. | -112.55 Million USD | -174.814% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -4358.229% |
| Rezolute, Inc. | -68.16 Million USD | -353.749% |
| Clene Inc. | 3.34 Million USD | 9360.836% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -2245.582% |
| BeyondSpring Inc. | -13.75 Million USD | -2148.723% |
| Synlogic, Inc. | -6.68 Million USD | -4526.954% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 27376.182% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3558.331% |
| Peak Bio, Inc. | 10.34 Million USD | 3091.365% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -275.287% |
| Krystal Biotech, Inc. | -350.23 Million USD | 11.684% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 349.194% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -83.029% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -9697.206% |
| MannKind Corporation | 143.89 Million USD | 314.951% |
| Ikena Oncology, Inc. | -109.15 Million USD | -183.367% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3985.483% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -834.477% |
| Gossamer Bio, Inc. | 180.35 Million USD | 271.502% |
| CohBar, Inc. | -5.93 Million USD | -5115.409% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -939.774% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 6874.242% |
| Legend Biotech Corporation | -949.39 Million USD | 67.42% |
| Mural Oncology plc | -255.84 Million USD | -20.899% |
| Disc Medicine, Inc. | -358.28 Million USD | 13.668% |
| Champions Oncology, Inc. | 4.81 Million USD | 6527.928% |
| REGENXBIO Inc. | 54.76 Million USD | 664.768% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -114925.606% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -104.81% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -3332.22% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -283.367% |
| Vaxart, Inc. | -8.24 Million USD | -3653.33% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -516.405% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -143.235% |
| Cellectis S.A. | -43.85 Million USD | -605.306% |
| Longeveron Inc. | -2.9 Million USD | -10536.586% |
| Repare Therapeutics Inc. | -107.85 Million USD | -186.777% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 131.941% |
| Inozyme Pharma, Inc. | 12 Million USD | 2676.74% |
| Revolution Medicines, Inc. | -608.2 Million USD | 49.143% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -25047.31% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -16.67% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -106.109% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1876.813% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -41698.906% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 96.766% |
| Denali Therapeutics Inc. | -74.86 Million USD | -313.16% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2479.383% |
| Veru Inc. | 4.77 Million USD | 6571.002% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2650.417% |
| Cingulate Inc. | 3.08 Million USD | 10133.854% |
| Passage Bio, Inc. | 4.58 Million USD | 6846.17% |
| Context Therapeutics Inc. | -14.44 Million USD | -2040.592% |
| Exicure, Inc. | 5.84 Million USD | 5388.287% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -34.264% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -681.683% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 2071.27% |
| Nuvalent, Inc. | -335.38 Million USD | 7.775% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 17934.55% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -315.284% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -3379.324% |
| OmniAb, Inc. | 9.2 Million USD | 3460.99% |
| Anew Medical, Inc. | 1.43 Million USD | 21692.982% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1988.149% |
| Lipocine Inc. | -4.75 Million USD | -6405.54% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -181.633% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 2130.805% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -510.576% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1342.616% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -4502.171% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -369.886% |
| Ocugen, Inc. | -32.52 Million USD | -851.114% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -261.451% |
| Q32 Bio Inc. | -37.94 Million USD | -715.094% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -49153.488% |
| Alumis Inc. Common Stock | -13.52 Million USD | -2186.288% |
| Equillium, Inc. | -22.39 Million USD | -1281.35% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -1109.762% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -848.031% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -124665.305% |
| Dominari Holdings Inc. | 195 Thousand USD | 158721.491% |
| Edesa Biotech, Inc. | -5.26 Million USD | -5772.74% |
| vTv Therapeutics Inc. | -8.91 Million USD | -3368.789% |
| Bio-Techne Corporation | 267.74 Million USD | 215.524% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1808.273% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -161.92% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3580.97% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -2344.96% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -26.188% |
| Nkarta, Inc. | 57.29 Million USD | 639.821% |
| BioCardia, Inc. | 212 Thousand USD | 146001.843% |
| Iterum Therapeutics plc | 13.43 Million USD | 2401.77% |